Rutgers Health researchers and other medical scientists involved in a large international study have identified new signs of kidney transplant ... signs of antibody-mediated rejection.

An investigational monoclonal antibody appeared to have therapeutic benefits among kidney transplant patients with antibody-mediated rejection, a randomized phase II trial showed. After 24 weeks ...

“Antibody-mediated rejection remains a significant challenge in kidney transplantation, with limited safer and effective treatment options currently available. With the potential to be disease ...

Each cell primed to the stimulating antigen(s) can be detected by the "spots", resulting from the binding of secreted cytokine with a labelled secondary antibody Helpful in predicting the risk of ...

“Most organ-failure patients today will never receive a lifesaving/life-changing transplant ... xenografts failed because of antibody mediated rejection, Makana deferred rushing to the clinic ...

Studies have shown that AlloSure Heart can detect biopsy proven Acute Cellular Rejection (ACR) and AMR (Antibody Mediated ... heart transplant recipient.” Simultaneous pancreas-kidney (SPK ...

Tutivia is a post-transplant blood test that helps detect a patient's risk of acute kidney rejection, including borderline, T cell-mediated, and antibody-mediated rejections. Verici said the test ...

“Antibody-mediated rejection remains a significant challenge in kidney transplantation, with limited safer and effective treatment options currently available. With the potential to be disease ...

In current clinical practice, immune reactivity of kidney transplant recipients ... with a labelled secondary antibody Helpful in predicting the risk of acute rejection Effective in tailoring ...

The Phase 3 study will evaluate the efficacy and safety of the investigational drug felzartamab compared to placebo in adult kidney transplant recipients diagnosed with late antibody-mediated ...

The Phase 3 study will evaluate the efficacy and safety of the investigational drug felzartamab compared to placebo in adult kidney transplant ... with late antibody-mediated rejection (AMR).